MedPAC to Congress: Put vaccines under Part B

Why This Topic Matters

The article highlights potential shifts in how Medicare would categorize preventive vaccines and certain overlapping drugs, along with payment methodology changes that could affect physician reimbursement. It is useful for understanding policy developments that may influence coverage, office administration, and practice expense calculations.

Article Sections

1. MedPAC vaccine coverage recommendations

   Discusses MedPAC’s recommendations regarding Medicare coverage categories for preventive vaccines and related access considerations.

2. Overlap drugs and Part B/Part D classification

   Summarizes MedPAC’s discussion of drugs that may fall under more than one Medicare benefit category and the administrative implications of reclassification.

3. Practice expense and geographic adjustment review

   Covers MedPAC’s review of Physician Fee Schedule practice expense methodology and geographic adjustment treatment for certain cost components.

4. Variation in practice expense by service type

   Notes the article’s comparison of how different services are affected by the composition of practice expense costs across specialties and procedures.

5. Pay-for-performance and clinical effectiveness entity proposal

   Describes MedPAC’s broader policy recommendation for an entity focused on evaluating the effectiveness of clinical services and sharing information with stakeholders.